| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Center for Health Sciences (Drs. Swan and Carmelli, and L.M. Jack), SRI International, Menlo Park, CA; the Department of Neurology (Dr. DeCarli), University of Kansas, Kansas City, KS; the Department of Neurology (Dr. Miller), Harbor-UCLA, Torrance, CA; the Department of Medical and Molecular Genetics (Dr. Reed), Indiana University School of Medicine, Indianapolis, IN; and the Department of Neurology (Dr. Wolf), Boston University, Boston, MA.
Address correspondence and reprint requests to Dr. Gary E. Swan, Center for Health Sciences, SRI International (formerly Stanford Research Institute), 333 Ravenswood Avenue, Menlo Park, CA 94025.
Objective: To investigate the association between midlife systolic blood pressure (SBP) and late-life cognitive decline and brain morphology in a sample of community-dwelling elderly men 68 to 79 years of age.
Methods: Subjects are surviving members from the prospective National Heart, Lung, and Blood Institute Twin Study (intake, 1969 to 1972) who, when examined for a fourth time in 1995 through 1997, underwent brain MRI and repeated assessment of neurobehavioral functioning. Quantification of the MR images determined cerebral volume and total volume of white matter hyperintensities (WMHIs) for 392 subjects. Midlife SBP levels measured in 1970, 1980, and 1985 were used to classify subjects into low, medium, and high midlife SBP categories. A 10-year change in performance on the Mini-Mental State Examination, Digit Symbol Substitution Test, Benton Visual Retention Test, and Verbal Fluency Test was also calculated for these subjects. For all reported analyses, patients were treated as genetically unrelated individuals.
Results: Subjects with high midlife SBP experienced a greater decline in cognitive performance and had larger WMHI volumes at follow-up in late life than did those with low midlife SBP. Decreased brain parenchyma and increased WMHI volumes were associated with decline in neurobehavioral functioning as measured in late life independent of age, education, and baseline levels of cognition.
Conclusions: Midlife SBP is a significant predictor of both decline in cognitive function and MR volumetric measures of brain atrophy in late life. Because decline in neurobehavioral functioning was associated with decreased brain volume and increased WMHI volume, we conclude that the long-term impact of elevated SBP on decline in late-life neurobehavioral functioning is likely to be mediated through its chronic, negative effect on structural characteristics of the brain.
Supported by grant HL51429 from the National Heart, Lung, and Blood Institute, Washington, DC.
Presented in part at the 49th annual meeting of the American Academy of Neurology; Boston, MA; April 1997.
Received March 4, 1998. Accepted in final form June 23, 1998.
This article has been cited by other articles:
|
|
 |
|
  X. Guo, L. Pantoni, M. Simoni, C. Bengtsson, C. Bjorkelund, L. Lissner, D. Gustafson, and I. Skoog Blood Pressure Components and Changes in Relation to White Matter Lesions: A 32-Year Prospective Population Study Hypertension, July 1, 2009; 54(1): 57 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B Rafnsson, I. J Deary, and F. Fowkes Peripheral arterial disease and cognitive function Vascular Medicine, February 1, 2009; 14(1): 51 - 61. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Viswanathan, W. A. Rocca, and C. Tzourio Vascular risk factors and dementia: How to move forward? Neurology, January 27, 2009; 72(4): 368 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Insel, S. L. Reminger, and C.-P. Hsiao White Matter Hyperintensities and Medication Adherence Biol Res Nurs, October 1, 2008; 10(2): 121 - 127. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Khatri, C. B. Wright, T. L. Nickolas, M. Yoshita, M. C. Paik, G. Kranwinkel, R. L. Sacco, and C. DeCarli Chronic Kidney Disease Is Associated With White Matter Hyperintensity Volume: The Northern Manhattan Study (NOMAS) Stroke, December 1, 2007; 38(12): 3121 - 3126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Debette, S. Bombois, A. Bruandet, X. Delbeuck, S. Lepoittevin, C. Delmaire, D. Leys, and F. Pasquier Subcortical Hyperintensities Are Associated With Cognitive Decline in Patients With Mild Cognitive Impairment Stroke, November 1, 2007; 38(11): 2924 - 2930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Viswanathan, A. Gschwendtner, J. -P. Guichard, F. Buffon, R. Cumurciuc, M. O'Sullivan, M. Holtmannspotter, C. Pachai, M. -G. Bousser, M. Dichgans, et al. Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL Neurology, July 10, 2007; 69(2): 172 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Kang, N. Cook, J. Manson, J. E Buring, and F. Grodstein Low dose aspirin and cognitive function in the women's health study cognitive cohort BMJ, May 12, 2007; 334(7601): 987 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Staessen, T. Richart, and W. H. Birkenhager Less Atherosclerosis and Lower Blood Pressure for a Meaningful Life Perspective With More Brain Hypertension, March 1, 2007; 49(3): 389 - 400. [Full Text] [PDF]
|
|
|
|
|
|
R. A. Shih, T. A. Glass, K. Bandeen-Roche, M. C. Carlson, K. I. Bolla, A. C. Todd, and B. S. Schwartz Environmental lead exposure and cognitive function in community-dwelling older adults Neurology, November 14, 2006; 67(9): 1556 - 1562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. DeStefano, L. D. Atwood, J. M. Massaro, N. Heard-Costa, A. Beiser, R. Au, P. A. Wolf, and C. DeCarli Genome-Wide Scan for White Matter Hyperintensity: The Framingham Heart Study Stroke, January 1, 2006; 37(1): 77 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. B. Wright, M. C. Paik, T. R. Brown, S. P. Stabler, R. H. Allen, R. L. Sacco, and C. DeCarli Total Homocysteine Is Associated With White Matter Hyperintensity Volume: The Northern Manhattan Study Stroke, June 1, 2005; 36(6): 1207 - 1211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Birns, H. Markus, and L. Kalra Blood Pressure Reduction for Vascular Risk: Is There a Price To Be Paid? Stroke, June 1, 2005; 36(6): 1308 - 1313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. den Heijer, L. J. Launer, N. D. Prins, E. J. van Dijk, S. E. Vermeer, A. Hofman, P. J. Koudstaal, and M. M.B. Breteler Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe Neurology, January 25, 2005; 64(2): 263 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Seshadri, P. A. Wolf, A. Beiser, M. F. Elias, R. Au, C. S. Kase, R. B. D'Agostino, and C. DeCarli Stroke risk profile, brain volume, and cognitive function: The Framingham Offspring Study Neurology, November 9, 2004; 63(9): 1591 - 1599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Elias, M. F. Elias, M. A. Robbins, and M. M. Budge Blood Pressure-Related Cognitive Decline: Does Age Make a Difference? Hypertension, November 1, 2004; 44(5): 631 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Mathew, S. K. Shernan, W. D. White, J. C.K. Fitch, J. C. Chen, L. Bell, and M. F. Newman Preliminary Report of the Effects of Complement Suppression With Pexelizumab on Neurocognitive Decline After Coronary Artery Bypass Graft Surgery Stroke, October 1, 2004; 35(10): 2335 - 2339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Jeerakathil, P. A. Wolf, A. Beiser, J. Massaro, S. Seshadri, R. B. D'Agostino, and C. DeCarli Stroke Risk Profile Predicts White Matter Hyperintensity Volume: The Framingham Study Stroke, August 1, 2004; 35(8): 1857 - 1861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. DeCarli, D. Mungas, D. Harvey, B. Reed, M. Weiner, H. Chui, and W. Jagust Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia Neurology, July 27, 2004; 63(2): 220 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Atwood, P. A. Wolf, N. L. Heard-Costa, J. M. Massaro, A. Beiser, R. B. D'Agostino, and C. DeCarli Genetic Variation in White Matter Hyperintensity Volume in the Framingham Study Stroke, July 1, 2004; 35(7): 1609 - 1613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Shumaker, C. Legault, L. Kuller, S. R. Rapp, L. Thal, D. S. Lane, H. Fillit, M. L. Stefanick, S. L. Hendrix, C. E. Lewis, et al. Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women: Women's Health Initiative Memory Study JAMA, June 23, 2004; 291(24): 2947 - 2958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Suhr, J. C. Stewart, and C. R. France The Relationship Between Blood Pressure and Cognitive Performance in the Third National Health and Nutrition Examination Survey (NHANES III) Psychosom Med, May 1, 2004; 66(3): 291 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Elias, L. M. Sullivan, R. B. D'Agostino, P. K. Elias, A. Beiser, R. Au, S. Seshadri, C. DeCarli, and P. A. Wolf Framingham Stroke Risk Profile and Lowered Cognitive Performance Stroke, February 1, 2004; 35(2): 404 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Chobanian, G. L. Bakris, H. R. Black, W. C. Cushman, L. A. Green, J. L. Izzo Jr, D. W. Jones, B. J. Materson, S. Oparil, J. T. Wright Jr, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension, December 1, 2003; 42(6): 1206 - 1252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Y. Wong, T. H. Mosley Jr., R. Klein, B. E.K. Klein, A. R. Sharrett, D. J. Couper, and L. D. Hubbard Retinal microvascular changes and MRI signs of cerebral atrophy in healthy, middle-aged people Neurology, September 23, 2003; 61(6): 806 - 811. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Pandav, H. H. Dodge, S. T. DeKosky, and M. Ganguli Blood Pressure and Cognitive Impairment in India and the United States: A Cross-National Epidemiological Study Arch Neurol, August 1, 2003; 60(8): 1123 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Heude, P. Ducimetiere, and C. Berr Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study Am. J. Clinical Nutrition, April 1, 2003; 77(4): 803 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Iadecola and P. B. Gorelick Converging Pathogenic Mechanisms in Vascular and Neurodegenerative Dementia Stroke, February 1, 2003; 34(2): 335 - 337. [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Wetherell, C. A. Reynolds, M. Gatz, and N. L. Pedersen Anxiety, Cognitive Performance, and Cognitive Decline in Normal Aging J. Gerontol. B. Psychol. Sci. Soc. Sci., May 1, 2002; 57(3): P246 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.-E. de Leeuw, J. C. de Groot, M. Oudkerk, J. C. M. Witteman, A. Hofman, J. van Gijn, and M. M. B. Breteler Hypertension and cerebral white matter lesions in a prospective cohort study Brain, March 1, 2002; 125(4): 765 - 772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. E. Swan and D. Carmelli Evidence for Genetic Mediation of Executive Control: A Study of Aging Male Twins J. Gerontol. B. Psychol. Sci. Soc. Sci., March 1, 2002; 57(2): P133 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W. Chow and C. H. MacLean Quality Indicators for Dementia in Vulnerable Community-Dwelling and Hospitalized Elders Ann Intern Med, October 16, 2001; 135(8_Part_2): 668 - 676. [Full Text] [PDF]
|
|
|
|
|
|
M. C. Morris, P. A. Scherr, L. E. Hebert, R. J. Glynn, D. A. Bennett, and D. A. Evans Association of Incident Alzheimer Disease and Blood Pressure Measured From 13 Years Before to 2 Years After Diagnosis in a Large Community Study Arch Neurol, October 1, 2001; 58(10): 1640 - 1646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Dufouil, A. de Kersaint-Gilly, V. Besancon, C. Levy, E. Auffray, L. Brunnereau, A. Alperovitch, and C. Tzourio Longitudinal study of blood pressure and white matter hyperintensities: The EVA MRI Cohort Neurology, April 10, 2001; 56(7): 921 - 926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. DeCarli, B. L. Miller, G. E. Swan, T. Reed, P. A. Wolf, and D. Carmelli Cerebrovascular and Brain Morphologic Correlates of Mild Cognitive Impairment in the National Heart, Lung, and Blood Institute Twin Study Arch Neurol, April 1, 2001; 58(4): 643 - 647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Knopman, L.L. Boland, T. Mosley, G. Howard, D. Liao, M. Szklo, P. McGovern, and A. R. Folsom Cardiovascular risk factors and cognitive decline in middle-aged adults Neurology, January 9, 2001; 56(1): 42 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hirono, H. Kitagaki, H. Kazui, M. Hashimoto, and E. Mori Impact of White Matter Changes on Clinical Manifestation of Alzheimer's Disease : A Quantitative Study Stroke, September 1, 2000; 31(9): 2182 - 2188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. E. Swan, C. DeCarli, B. L. Miller, T. Reed, P. A. Wolf, and D. Carmelli Biobehavioral characteristics of nondemented older adults with subclinical brain atrophy Neurology, June 13, 2000; 54(11): 2108 - 2114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Gorelick Can we save the brain from the ravages of midlife cardiovascular risk factors? Neurology, April 1, 1999; 52(6): 1114 - 1114. [Full Text] [PDF]
|
|
|
|
|
|
C. DeCarli, B. L. Miller, G. E. Swan, T. Reed, P. A. Wolf, J. Garner, L. Jack, and D. Carmelli Predictors of Brain Morphology for the Men of the NHLBI Twin Study Stroke, March 1, 1999; 30(3): 529 - 536. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
